Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
for doctoral/third-cycle/PhD education if you: have been awarded a second-cycle/advanced/master qualification (i.e. master degree), or have satisfied the requirements for courses comprising at least 240 credits
-
PhD-level and masters-level statisticians, and doctoral students. The group is involved in a wide variety of research projects, including the development of statistical methods, population-based cohort
-
launched with the recruitment of 20 academic and 7 industrial PhD students. During the course of the DDLS program more than 260 PhD students and 200 postdocs will be part of the Research School. The DDLS
-
You meet the general eligibility requirement for doctoral/third-cycle/PhD education if you: have been awarded a second-cycle/advanced/master qualification (i.e. master degree), or have satisfied
-
geneticists, psychologists, psychiatrists, and statisticians. The group is based at the Department of Medical Epidemiology and Biostatistics, where the the Phd student will also work. The doctoral student
-
) General eligibility requirement You meet the general eligibility requirement for doctoral/third-cycle/PhD education if you: have been awarded a second-cycle/advanced/master qualification (i.e. master degree
-
of the doctoral student The research project PhD students are expected to take a leading role in the entire research process under the guidance of their PhD supervisors. By participating in study design, data
-
scientific reports and manuscripts linked to the project. Moreover the student is expected to prepare scientific presentations linked to the project. This PhD project aim to equip the student with a broad
-
phenotypes. In this PhD you will address this by a deep learning model of drug responses in cancer. The PhD position focuses on predicting cell type-specific drug responses, identifying transcriptional
-
for classification of lung cancer subtype based on the generated MS-data. Finally, the student will evaluate the applicability and value of the developed clinical proteomics methods in a clinical setting. The PhD